284 related articles for article (PubMed ID: 17238810)
1. Voriconazole and fungal keratitis: a report of two treatment failures.
Giaconi JA; Marangon FB; Miller D; Alfonso EC
J Ocul Pharmacol Ther; 2006 Dec; 22(6):437-9. PubMed ID: 17238810
[TBL] [Abstract][Full Text] [Related]
2. Topical and oral voriconazole in the treatment of fungal keratitis.
Bunya VY; Hammersmith KM; Rapuano CJ; Ayres BD; Cohen EJ
Am J Ophthalmol; 2007 Jan; 143(1):151-3. PubMed ID: 17188052
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of Fusarium keratitis with cornea transplantation and topical and systemic voriconazole.
Klont RR; Eggink CA; Rijs AJ; Wesseling P; Verweij PE
Clin Infect Dis; 2005 Jun; 40(12):e110-2. PubMed ID: 15909252
[TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro investigations of fungal keratitis caused by Colletotrichum gloeosporioides.
Mitani A; Shiraishi A; Uno T; Miyamoto H; Hara Y; Yamaguchi M; Ohashi Y
J Ocul Pharmacol Ther; 2009 Dec; 25(6):563-5. PubMed ID: 20028265
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting treatment outcomes with voriconazole in cases with fungal keratitis.
Ramakrishnan T; Constantinou M; Jhanji V; Vajpayee RB
Cornea; 2013 Apr; 32(4):445-9. PubMed ID: 22580440
[TBL] [Abstract][Full Text] [Related]
6. The effects of intrastromal voriconazole injection and topical voriconazole in the treatment of recalcitrant Fusarium keratitis.
Siatiri H; Daneshgar F; Siatiri N; Khodabande A
Cornea; 2011 Aug; 30(8):872-5. PubMed ID: 21448063
[TBL] [Abstract][Full Text] [Related]
7. Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis.
Thiel MA; Zinkernagel AS; Burhenne J; Kaufmann C; Haefeli WE
Antimicrob Agents Chemother; 2007 Jan; 51(1):239-44. PubMed ID: 17060517
[TBL] [Abstract][Full Text] [Related]
8. Voriconazole versus natamycin as primary treatment in fungal corneal ulcers.
Arora R; Gupta D; Goyal J; Kaur R
Clin Exp Ophthalmol; 2011 Jul; 39(5):434-40. PubMed ID: 21105974
[TBL] [Abstract][Full Text] [Related]
9. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens.
Marangon FB; Miller D; Giaconi JA; Alfonso EC
Am J Ophthalmol; 2004 May; 137(5):820-5. PubMed ID: 15126145
[TBL] [Abstract][Full Text] [Related]
10. Successful salvage treatment of Scedosporium apiospermum keratitis with topical voriconazole after failure of natamycin.
Al-Badriyeh D; Leung L; Davies GE; Stewart K; Kong D
Ann Pharmacother; 2009 Jun; 43(6):1139-42. PubMed ID: 19435962
[TBL] [Abstract][Full Text] [Related]
11. Topical voriconazole as a novel treatment for fungal keratitis.
Sponsel W; Chen N; Dang D; Paris G; Graybill J; Najvar LK; Zhou L; Lam KW; Glickman R; Scribbick F
Antimicrob Agents Chemother; 2006 Jan; 50(1):262-8. PubMed ID: 16377696
[TBL] [Abstract][Full Text] [Related]
12. The use of voriconazole in the management of post-penetrating keratoplasty Paecilomyces keratitis.
Deng SX; Kamal KM; Hollander DA
J Ocul Pharmacol Ther; 2009 Apr; 25(2):175-7. PubMed ID: 19284327
[TBL] [Abstract][Full Text] [Related]
13. Successful use of topical voriconazole 1% alone as first-line antifungal therapy against Candida albicans keratitis.
Al-Badriyeh D; Leung L; Davies GE; Stewart K; Kong D
Ann Pharmacother; 2009 Dec; 43(12):2103-7. PubMed ID: 19861430
[TBL] [Abstract][Full Text] [Related]
14. The successful medical treatment of a case of Paecilomyces lilacinus keratitis.
Wu PC; Lai CH; Tan HY; Ma DH; Hsiao CH
Cornea; 2010 Mar; 29(3):357-8. PubMed ID: 20098311
[TBL] [Abstract][Full Text] [Related]
15. Activity of voriconazole against corneal isolates of Scedosporium apiospermum.
Shah KB; Wu TG; Wilhelmus KR; Jones DB
Cornea; 2003 Jan; 22(1):33-6. PubMed ID: 12502945
[TBL] [Abstract][Full Text] [Related]
16. The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole.
Prajna NV; Krishnan T; Mascarenhas J; Rajaraman R; Prajna L; Srinivasan M; Raghavan A; Oldenburg CE; Ray KJ; Zegans ME; McLeod SD; Porco TC; Acharya NR; Lietman TM;
JAMA Ophthalmol; 2013 Apr; 131(4):422-9. PubMed ID: 23710492
[TBL] [Abstract][Full Text] [Related]
17. Management of tunnel fungal infection with voriconazole.
Jhanji V; Sharma N; Mannan R; Titiyal JS; Vajpayee RB
J Cataract Refract Surg; 2007 May; 33(5):915-7. PubMed ID: 17466872
[TBL] [Abstract][Full Text] [Related]
18. Determination of in vitro susceptibility of ocular Fusarium spp. isolates from keratitis cases and comparison of Clinical and Laboratory Standards Institute M38-A2 and E test methods.
Iqbal NJ; Boey A; Park BJ; Brandt ME
Diagn Microbiol Infect Dis; 2008 Nov; 62(3):348-50. PubMed ID: 18707841
[TBL] [Abstract][Full Text] [Related]
19. Antifungal efficacy of voriconazole, itraconazole and amphotericin b in experimental fusarium solani keratitis.
Yavas GF; Oztürk F; Küsbeci T; Cetinkaya Z; Ermis SS; Kiraz N; Inan UU
Graefes Arch Clin Exp Ophthalmol; 2008 Feb; 246(2):275-9. PubMed ID: 17912543
[TBL] [Abstract][Full Text] [Related]
20. [Use of topical voriconazole in Alternaria keratitis].
De-Domingo-Barón B; Rodríguez-Ares T; Touriño-Peralba R; Pardo-Sánchez F; Romero-Jung P; Barcia M
Arch Soc Esp Oftalmol; 2008 Aug; 83(8):493-5. PubMed ID: 18661446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
